TABLE 2.

Diagnostic performance of recombinant EmAgB3 (EmuJ_000381600)

Disease category	No. positive/no. tested	% sensitivity	% specificity
AE
Early	44/48	91.7
Advanced	36/40	90
Follow-up	0/33		100
>1 yrs	0/13		100
1–2 yrs	0/20		100
CE
Stage 1	1/23		95.7
Stage 2	3/16		81.4
Stage 3	2/27		92.6
Stage 4	1/21		95.2
Stage 5	1/14		92.9
Neurocysticercosis	0/100		100
Sparganosis	0/50		100
Clonorchiasis	1/87		98.9
Fascioliasis	0/30		100
Schistosomiasis japonicum	0/21		100
Paragonimiasis	0/30		100
Liver cirrhosis	0/23		100
Liver cyst	0/23		100
Hepatocellular carcinoma	0/18		100
Liver mass	0/20		100
Normal control	0/103		100
Overalla	80/88	90.9
	9/606		98.5

^aOverall sensitivity and specificity were calculated employing 88 active-stage-AE sera and 606 other sera, respectively.